Closed
The Marked Chart Wire · Health
Stoke Therapeutics
Stoke Therapeutics said it expects to report results from its EMPEROR trial in the third quarter of 2027. The company also plans to submit a new drug application to regulators in the second half of 2027.
New to this? Read: Reading a stock chart
FDA
The US Food and Drug Administration has approved revised labeling for three estradiol patch products.
Velo
The Food and Drug Administration granted marketing approval to 24 Velo nicotine pouch items, marking a significant regulatory achievement for British American Tobacco.
Eli Lilly
Eli Lilly stock climbed 1.89 percent in after-hours trading following favorable Phase 3 data for its diabetes drug retatrutide, ahead of upcoming quarterly earnings.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.